Demant A/S Unsponsored ADR (OTCMKTS:WILYY – Get Free Report) hit a new 52-week high on Thursday. The company traded as high as $26.66 and last traded at $26.66, with a volume of 129 shares changing hands. The stock had previously closed at $24.80.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on WILYY shares. UBS Group cut Demant A/S from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, July 22nd. Zacks Research downgraded shares of Demant A/S from a “strong-buy” rating to a “hold” rating in a research note on Monday. Morgan Stanley raised shares of Demant A/S from an “equal weight” rating to an “overweight” rating in a report on Tuesday, June 23rd. Finally, Sanford C. Bernstein downgraded shares of Demant A/S from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.
Get Our Latest Analysis on Demant A/S
Demant A/S Stock Performance
The business’s 50-day moving average is $23.21 and its 200-day moving average is $20.16.
Demant A/S Company Profile
Demant A/S is a Denmark-based hearing healthcare company that develops, manufactures and distributes products and services designed to help people with hearing loss and other communication needs. The company serves consumers and hearing care professionals through activities spanning hearing aids, diagnostic equipment, hearing care services and specialized communications technology.
Its portfolio includes hearing aids and related software, audiological diagnostic instruments, and technologies used by hearing care professionals to assess and manage hearing conditions.
See Also
- Five stocks we like better than Demant A/S
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.
